HUM Looks 5.8% Overvalued on GF Value™ as Dividend Holds Steady
Humana Inc (HUM) declared a quarterly dividend of $0.885 per share, maintaining its prior payout. The stock trades at $394.88, 5.8% above its GF Value™ of $373.21, with a GF Score™ of 84. Insiders have shown net buying. The company's P/E ratio is 37.32x, higher than its 5-year median of 21.26x.
How this was made
The 30-second read
Why it matters
The unchanged dividend reinforces the company's commitment to returning capital but does not materially shift valuation metrics.
Market read
Dividend announcement with no change offers limited trading impetus; relevance mainly for income-focused portfolios.
What to watch
Potential upcoming regulatory changes or Medicare policy shifts could affect future cash flows.
Background
Humana is a major U.S. health insurer with a market cap of $47.42B, trading on NYSE under HUM.
Ticker impact
Humana announced a quarterly dividend of $0.885 per share, unchanged from prior, with record and payable dates in October/November 2026.
Minor price pressure or flat movement as the dividend does not alter valuation expectations.
Dividend announcements are routine; the lack of change and modest yield suggest limited market reaction.
Market effects
Provides a modest income signal for the healthcare insurance sector, but overvaluation concerns persist.
Limited impact confined to U.S. healthcare investors.
Low global relevance; primarily of interest to dividend-focused investors.
Counterpoint
Investors seeking growth may view the dividend as a distraction from underlying valuation stretch.
Key entities
- companyHumana Inc.
U.S. health insurance provider.
